Amplicon showcased its leading consumer product in Warsaw

Amplicon, a wholly owned subsidiary of Emplicure AB that focuses on developing consumer products, successfully showcased two dry white nicotine-pouch products at the Global Forum on Nicotine in Warsaw on 16-18 June 2022.

The technology springs from Amplicon's IP, based on ceramic biomaterials, and represents a completely new generation of nicotine products with distinct properties for enhanced user experiences that target the rapidly growing global market for nicotine pouches.

Amplicon's stand at GFN was well visited by industry representatives, researchers, consumer advocate groups and members of the media. In particular, the samples of the two nicotine products that representatives from Amplicon shared with many GFN visitors, sparked much interest. 

The response at GFN was remarkable," says Tomas Hammargren, Chairman of Amplicon. "It's clear that after meeting with so many principal parties in our industry that we have developed something significant. The acknowledgement from our peers reinforces our conviction that Amplicon has a vital role to play in this market."  

In connection with GFN, Professor Håkan Engqvist, board member and co-founder of Emplicure, held a presentation of Amplicon's products for a large audience at ISoNTech on Thursday, 16 June 2022. The presentation, titled "The First Dry Pouch With Long-lasting Diffusion of Taste and Nicotine" sparked a stimulating discussion and a number of questions from the audience about Amplicon's platform and products.

"The interest in our presentation was truly gratifying, but more importantly, the curiosity shown by researchers and industry representatives from all over the world in our technology and its potential was exactly the kind of positive input that we had hoped for," says Håkan Engqvist. 

ISoNTech is a distinct 1-day event that takes place in June each year. Developers, manufacturers and distributors are invited to demonstrate new products and discuss their design and development. The aim is to present a wide range of alternative delivery systems, including vaping products, oral pouches and tobaccos and heated tobacco products as well as ancillary technologies involved.

GFN is the only international conference that focuses on the important role that safer nicotine products have in helping people quit smoking. Safer nicotine products include e-cigarettes (so-called vapes), nicotine pouches, oral tobacco, such as Swedish snus, and heated tobacco products.

Amplicon announced on June 15 that it filed at the European Union Intellectual Property Office (EUIPO) for a trademark registration for its leading product.

For more information, please contact:

Torbjörn W. Larsson
Phone: +46 (0)70 747 65 99
Email: [email protected]

Erik Magnusson
CFO, Investor Relations
Phone: +46 (0)708 565 245
Email: [email protected]

Tomas Hammargren
Chairman, Amplicon AB
Phone: +46 (0) 706 494 549
Email: [email protected]

Emplicure AB (publ) is listed on the Nasdaq First North Growth Market. Certified Adviser is Mangold Fondkommission AB, +46 8 503 015 50, or via [email protected]

Emplicure is a pharmaceutical company developing new and innovative drugs by combining existing and approved active substances, and advanced materials science within ceramic biomaterials. The product portfolio is focused on chronic pain, and with abuse deterrent formulations. The wholly owned subisidiary, Amplicon AB develops consumer products, with white tobacco-free nicotine pouches as the first product. Read more at

Emplicure anlitar Erik Penser Bank som likviditetsgarant

Emplicure AB (publ) har utsett Erik Penser Bank AB ("Penser") till likviditetsgarant för Bolagets aktie. Syftet är att förbättra aktiens likviditet och Pensers uppdrag inleds den 24 november 2022.

Emplicure engages Erik Penser Bank as liquidity provider

Emplicure AB (publ) today announced that the company has entered into an agreement with Erik Penser Bank ("Penser") whereby Penser will act as liquidity provider for the Emplicure share, starting 24 November 2022.

Kommuniké från extra bolagsstämma i Emplicure AB (publ)

Extra bolagsstämma i Emplicure AB (publ) ("Bolaget") ägde rum kl. 11.00 måndagen den 14 november 2022 i Bolagets lokaler, Virdings allé 32B, Uppsala.

Communiqué from extraordinary general meeting in Emplicure AB (publ)

An extraordinary general meeting in Emplicure AB (publ) (the "Company") was held on Monday 14 November 2022 at 11 am at the Company's premises, Virdings allé 32B, Uppsala.

Emplicure upptar lån om 9,0 MSEK

Emplicure AB (publ) har idag ingått ett låneavtal med ett konsortium av långivare genom vilket Bolaget upptagit ett lån om 9,0 MSEK. Lånekonsortiet inkluderar vissa befintliga aktieägare, däribland styrelseledamoten Johan Wieslander. Syftet med lånet är att kortsiktigt stärka bolagets rörelsekapital samt att möta kravet på befintligt aktiekapital för att driva bolaget den närmaste tolvmånadersperioden.

Emplicure takes up a loan in the amount of 9.0 MSEK

Emplicure AB (publ) has today entered into a loan agreement with a loan consortium through which the Company has taken up a loan in the amount of 9.0 MSEK. The loan consortium includes certain existing shareholders, including the board member Johan Wieslander. The purpose of the loan is to strengthen the Company's short-term working capital and to meet the requirement of going concern for the next twelve months.

Emplicure utser valberedning

Emplicure AB meddelar idag att valberedningen har utsetts inför stämman i maj 2023. Valberedningen består av representanter för de tre största aktieägarna per den sista bankdagen i tredje kvartalet, jämte styrelsens ordförande. Bolagets tre största aktieägare, tillika grundare, har enats om att rösta som en genom Thomas Lundqvist, för att ge företräde till oberoende aktieägare.

Emplicure has formed Nomination Comittee

Emplicure AB announces today that the Nomination Committee for the annual general shareholders meeting (AGM) in May 2023 is formed. The Nomination Committee  consists of representatives nominated by the three largest shareholders per the last bank-day in the third quarter, as well as the Chairman of the Board. Emplicure's three largest shareholders, also the founders, have agreed to vote as one, in order to give preference for more shareholders.

Dosering i fas I PK-studie för EMPLI03 slutförd

Emplicure AB rapporterar genomförd dosering i den första fas I farmakokinetikstudien med EMPLI03, avsedd för behandling av medelsvår till svår smärta

Dosing in Phase I PK study for EMPLI03 completed

Emplicure AB today reported dosing in the first Phase I pharmacokinetic study for EMPLI03, intended for the treatment of moderate to severe pain

Emplicure byter Certified Adviser till Erik Penser Bank AB

Uppsala 2022-10-03 Emplicure AB (publ) meddelade idag att bolaget byter Certified Adviser

Emplicure changes Certified Adviser to Erik Penser Bank AB

Uppsala, 2022-10-03 Emplicure AB (publ) today announced that the company changes Certified Adviser

Emplicure genomför holdingbolagsstruktur

Uppsala 2022-09-19 Emplicure AB (publ) meddelar idag att bolagets styrelse beslutat att genomföra en holdingbolagsstruktur med operativa dotterbolag. Syftet med omstruktureringen är att synliggöra och förstärka koncernens möjlighet att fokusera på affärs- och produktutvecklingen inom flera olika produktområden, såväl nikotin, läkemedel som andra konsumentproduktområden. Som en direkt följd av ovanstående har styrelsen utsett Tomas Hammargren till vd i dotterbolaget Amplicon.

Emplicure adopts a holding company structure

Uppsala 2022-09-19 Emplicure AB (publ) announces today that the Company's Board of Directors has resolved to implement a holding company structure with operational subsidiaries. The purpose of the restructuring is to increase visibility and reinforce the Group's ability to focus on business and product development across various product areas, including nicotine and pharmaceuticals as well as other consumer product areas. As a direct consequence of the above, the Board of Directors has appointed Tomas Hammargren as CEO of the subsidiary Amplicon.

Håkan Engqvist ny VD på Emplicure

Uppsala 2022-09-19 Emplicure AB (publ) meddelar idag att bolagets styrelse beslutat att utse styrelsemedlemmen och medgrundaren Håkan Engqvist till ny vd och koncernchef.

Håkan Engqvist new CEO of Emplicure

Uppsala 2022-09-19 Emplicure AB (publ) announces today that the Company's Board of Directors has resolved to appoint member of the board and co-founder Håkan Engqvist as new CEO and President. 

Följ oss

Om beQuoted

beQuoted publicerar nyheter, analyser och pressmeddelanden för investerare och journalister. Viktiga företagshändelser bevakas av vår egen nyhetsredaktion och vidaredistribueras i ledande finansiella medier.

Vi uppdaterar även nyhetsrum, Investor Relations och IR-webbplatser för företag som vill utveckla sina relationer med finansmarknaden.

Kontakta oss

beQuoted AB
Nybrogatan 34
Box 5216
102 45 Stockholm

08-692 21 90

Om beQuoted